Vous pouvez maintenant accéder à la version de decembre 2024 du Répertoire canadien des médicaments à partir de Terminology Gateway et du serveur terminologique, à des fins de consultation ou d’implantation.
En savoir plus >
Hello Monica
We are not addressing "de-prescribing" we are addressing the description of mineral oil products in CCDD in this paper.
Please let us know if this answers your query.
The CCDD Team has been looking at how to describe the TMs (therapeutic moities) and NTPs (non-proprietary therapeutic products) for products containing mineral oil as an active ingredient substance. The attached document summaries the information and the rationale for the choice of the two concepts that will be used in the CCDD: